Searched for
GLENMARK GENERICS LTD
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Glenmark gets USFDA nod for post-menopause osteoporosis drugThe approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenma...
- Glenmark gets USFDA nod to sell generic blood pressure drug TarkaThe approval for trandolapril and verapamil hydrochloride extended release tablets has been granted to Glenmark Generics Inc.
- Glenmark Generics gets US FDA nod for ulcer treatment drugGlenmark's current portfolio consists of 94 products authorised for distribution in the US market and 72 ANDAs are pending approval with th...
- Glenmark to launch anti-hypertension drug in US, gets USFDA nodGlenmark's current portfolio consists of 92 products authorised for distribution in the US market and 73 ANDAs are pending approval with th...
- Glenmark Generics Inc files law suit to enforce licence pactThe agreement is with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV.
- Glenmark confirms patent challenge for its generic versions of VIMPAT in the US CourtGlenmark Generics Ltd confirms that it has filed ANDAs for Lacosamide tablets and oral solution with the US drug authorities with a Paragra...
- Glenmark receives ANDA approval for its contraceptive pillsGlenmark Generics Inc., USA, a subsidiary of Glenmark Glenmark on Monday announced they have been granted final approval for their abbrevia...
- Glenmark Pharmaceuticals gets USFDA approval for oral contraceptivesGlenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic two oral contraceptives tab...
- Glenmark US arm gets tentative USFDA nod for migraine tabletsGlenmark said its US subsidiary has received tentative approval from the US health regulator for its generic Zolmitriptan tablets.
- Glenmark gets US FDA nod to sell painkiller drug in USThe approval is for 5 mg capsule and 100 mg/5 ml oral solution, Glenmark Generics Inc and LVT have also signed a new supply and marketing a...
- Sebi approves IPO of Glenmark’s generics armThe Securities and Exchange Board of India (Sebi) has approved the initial public offering (IPO) of Glenmark Generics, the wholly-owned sub...
- CRISIL assigns IPO grade 4/5 to Glenmark GenericsCRISIL has assigned IPO Grade 4/5 to the proposed IPO of Glenmark Generics Ltd, which indicates that the fundamentals of the IPO are above ...
- Glenmark Generics files for IPOGlenmark Generics, the generics arm of Glenmark Pharmaceuticals, on Wednesday filed the draft prospectus with Sebi to raise Rs 550-600 cror...
- Glenmark to reorganise biz into two unitsThe company’s generic business will come under a wholly owned subsidiary, Glenmark Generics, while innovative research initiatives and bran...
- Glenmark to reorganise biz into specialty, genericsThe new generic entity, called Glenmark Generics, will be a subsidiary of the company and will be listed on the bourses by April-June 2008-...
Load More
